Delivery Order SPE2DB22D1017-SPE2DB24FF5LK
Award Date 4/5/24
Potential Completion Date 4/26/24
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of Zeposia 0.92 mg capsules, a specialty pharmaceutical product, with a ceiling value of $13,399.71 and a performance period through May 2, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the medication Zeposia 0.92 mg Capsule 30s, with a ceiling value of $13,862.79 and a performance period through May 21, 2025. This contract is not set-aside and was awarded as part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Zeposia 0.92 mg capsules. The contract has a firm fixed price of $13,862.79 and a performance period ending on July 30, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zeposia 0.92 MG Capsule 30S, a pharmaceutical product. The contract has a ceiling value of $18,483.72 and a completion date of February 28, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,862.79, is for the delivery of Zeposia 0.92 mg capsules. Zeposia is a medication used to treat certain neurological conditions. The contract is a firm fixed-price, non-set-aside award with a performance period through May 2025. AmerisourceBergen Drug Corp also holds a larger Indefinite...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,466.57 award is for the supply of the medication Zeposia 0.92 mg capsules. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product Zeposia 0.92 MG Capsule 30S. The contract is a firm fixed-price delivery order with a ceiling value of $13,399.71 and a completion date of July 22, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a single-award Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Zeposia 0.92 mg capsules in a 30-count package to the Defense Logistics Agency (DLA), a defense agency. The $17,866.28 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units) with a ceiling value of $9,241.86. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $13,399.71 firm fixed price delivery order is for the supply of 4,565,730,589 units of Zeposia 0.92 MG Capsule 30S, a specialty pharmaceutical product. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...